Painchek Ltd has released a press release.
New Peer reviewed published study
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from PainChek
- 2nd peer-review confirms excellent performance of PainChek
- ePAT and PainChek continue to achieve commercial milestones
- Placement to raise $3.75 million
- Core strategic agreement with Dementia Support Australia
- ePAT Clinical Study Published in Alzheimers Disease Journal
Later from PainChek
- PainChek App Android version now in beta testing
- Half Year Report and Financial Statements
- Agreement signed with leading software system provider
- PainChek receives FDA regulatory guidance
- New publication confirms accuracy of PainChek(R)
Follow PainChek into a list and get an email when it puts out news.
Follow PainChek